A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled studies, were recently authorized in most countries for adults with chronic immune thrombocytopenia. So far, no data are available about the po...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Khellaf, Mehdi, Viallard, Jean-François, Hamidou, Mohamed, Cheze, Stéphane, Roudot-Thoraval, Françoise, Lefrere, François, Fain, Olivier, Audia, Sylvain, Abgrall, Jean-François, Michot, Jean-Marie, Dauriac, Charles, Lefort, Sophie, Gyan, Emmanuel, Niault, Mathilde, Durand, Jean-Marc, Languille, Laetitia, Boutboul, David, Bierling, Philippe, Michel, Marc, Godeau, Bertrand
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ferrata Storti Foundation 2013
Onderwerpen:
Original Articles and Brief Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669443/
https://ncbi.nlm.nih.gov/pubmed/23445876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.074633
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items